New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
The Pharma Data
JANUARY 15, 2021
15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. Right now, no medication is approved specifically for pulmonary hypertension caused by ILD, said Dr. Steven Nathan, senior researcher on the new trial. FRIDAY, Jan.
Let's personalize your content